Home › Drug Codes › NOC Codes › LUMVOA
HCPCS Unassigned

LUMVOA

veligrotug-vvze · Viridian Therapeutics

Login to unlock all benchmarks
Miscellaneous Code ?
J3590
bill until Dec 31, 2026
Permanent Code ?
J3242
effective Jan 1, 2027
WAC ?
Subscribe to view
AWP ?
Subscribe to view
NDCs Listed
1
Subscribe to view

Drug & Product Overview

Permanent Code Descriptor (from Jan 1, 2027) Injection, veligrotug-vvze, 1 mg
Miscellaneous Billing Code J3590
FDA Approval Date June 26, 2026
Manufacturer Viridian Therapeutics
Active Ingredient veligrotug-vvze
Route of Administration Intravenous
Dosage Form Injection

How to Bill LUMVOA Now

Through December 31, 2026, bill LUMVOA with J3590, the code for unclassified biologics, and identify the product by its NDC. From January 1, 2027, bill J3242.

Setting Claim Form Billing Code Notes
Physician office / Part B CMS-1500 / 837P J3590 Enter the drug name, dose and NDC in Item 19 (or the 837P equivalent). The MAC prices the claim manually.
Hospital outpatient (OPPS) UB-04 / 837I C9399 Unclassified drug or biological. Separately payable and priced manually by the MAC.
Required Claim Documentation
Drug name and dosage administered National Drug Code (NDC) of the product given Total quantity administered, in the applicable unit of measure Date the drug was administered

About LUMVOA

LUMVOA (veligrotug-vvze) is an intravenous infusion from Viridian Therapeutics for thyroid eye disease regardless of thyroid eye disease activity or duration. It was approved by the FDA on June 26, 2026.

LUMVOA Pricing & NDCs

Package WAC and AWP for each NDC, updated monthly. There's no ASP payment limit until a permanent code takes effect.

NDC Code Package WAC AWP

1 NDC on file. Subscribe to see its package, WAC and AWP, with monthly history.

HCPCS Code Status

As of Nov 5, 2026
Today · through Dec 31, 2026
J3590
Unclassified biologics
Effective Jan 1, 2027
J3242
Injection, veligrotug-vvze, 1 mg

J3590 claims for LUMVOA with dates of service on or after January 1, 2027 will be denied. Confirm coding with your payer before billing.

LUMVOA Clinical Information

Treated Diseases & Conditions
Thyroid eye disease regardless of thyroid eye disease activity or duration

Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with Pro

Pro includes:

  • ASP, WAC and AWP for every drug
  • NDC package pricing
  • 10+ years of price history
  • Side-by-side Analytics in the Comparative Report

Card required · cancel anytime

Frequently Asked Questions

What HCPCS code is used for LUMVOA?

J3590 (unclassified biologics) for dates of service through December 31, 2026, and its permanent code J3242 from January 1, 2027. Hospital outpatient claims use C9399 until the permanent code takes effect.

What NDC goes on a LUMVOA claim?

The NDC of the package you administered. Subscribers can see LUMVOA’s NDCs with package, WAC and AWP.

Is there an ASP-based Medicare payment limit for LUMVOA?

Not yet. CMS sets ASP-based payment limits for permanent codes. Until then the MAC prices LUMVOA claims manually.

Where can I find the full prescribing information?